Codes / ICD10CM / T43.502D

T43.502D Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, subsequent encounter

Summary

This code represents intentional self-harm poisoning from unspecified antipsychotics or neuroleptics during a subsequent encounter. Antipsychotics and neuroleptics treat psychiatric conditions, and intentional self-harm poisoning occurs when a patient takes more than the prescribed dose with the intent to cause harm. The "subsequent encounter" designation applies when the patient is receiving active treatment for the condition during a later episode of care. Clinical documentation must specify the intentional self-harm nature and the subsequent encounter status for accurate coding.

Causes

Intentional self-harm poisoning by antipsychotics or neuroleptics typically results from deliberate overdose, often associated with underlying mental health conditions. The unspecified nature of the drug means the exact agent is not documented in the record. This scenario is part of a continuum of self-harm behaviors and may involve repeated or ongoing episodes requiring follow-up care.

Risk Factors

  • History of mental health conditions (e.g., depression, bipolar disorder)
  • Prior suicide attempts or ideation
  • Access to medications without supervision
  • Substance use disorders
  • Social isolation or acute life stressors
  • Previous self-harm episodes requiring ongoing care

Symptoms

  • Drowsiness or excessive sedation
  • Confusion or altered mental status
  • Rapid heart rate or irregular heartbeat
  • Seizures or tremors
  • Nausea, vomiting, or gastrointestinal distress
  • Low blood pressure
  • Respiratory depression

Diagnosis

Diagnosis involves assessing the patient's medication history, clinical presentation, and intent. Documentation must confirm intentional self-harm and the subsequent encounter status. Laboratory tests may identify drug presence, though the unspecified nature of the agent limits specificity. Clinical evaluation focuses on the patient's mental state and any residual effects of the poisoning.

Treatment Options

Treatment addresses both the immediate effects of poisoning and the underlying mental health concerns. This may include monitoring for complications, managing symptoms (e.g., sedation, seizures), and initiating or adjusting psychiatric care. Long-term management often involves therapy, medication review, and safety planning to prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning and the patient's mental health stability. Subsequent encounters indicate ongoing care, which may involve regular monitoring, therapy, and medication adjustments. Follow-up is critical to address recurrence risk and support recovery.

Complications

  • Respiratory failure or arrest
  • Cardiac arrhythmias or arrest
  • Seizures or status epilepticus
  • Coma or persistent altered mental status
  • Long-term psychiatric or cognitive effects
  • Risk of repeated self-harm episodes

Lifestyle & Prevention

  • Secure storage of medications to limit access
  • Regular mental health evaluations and therapy
  • Medication management education for patients and caregivers
  • Development of safety plans with healthcare providers
  • Support from social services or crisis intervention teams

When to Seek Professional Help

Seek immediate medical attention for symptoms of poisoning, such as severe drowsiness, confusion, seizures, or difficulty breathing. Ongoing psychiatric care is essential for managing underlying conditions and reducing self-harm risk.

Tips for Medical Coders

This code requires documentation of intentional self-harm and a subsequent encounter. The "subsequent encounter" modifier applies when the patient is receiving active treatment for the condition during a later episode of care. Ensure clinical records specify the intent (intentional self-harm) and the encounter type to support accurate coding. The unspecified nature of the drug means no specific agent is documented, which is consistent with the code's structure.

Book a walkthrough

T43.502D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.